Noel B. Geer - 06 May 2022 Form 4 Insider Report for Leidos Holdings, Inc. (LDOS)

Reporting relationship: Director
Issuer ticker: LDOS
Reported as of: 06 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 May 2022, 17:45:38 UTC
Prior SEC filing: 16 Mar 2022
Next SEC filing: 24 Feb 2023
Source filing: View source filing
Reporting owner signature: Ramune M. Kligys, Attorney-in-Fact

Key filing fact

Noel B. Geer filed Form 4 for Leidos Holdings, Inc. (LDOS) on 10 May 2022.

Key facts

This page summarizes Noel B. Geer's Form 4 filing for Leidos Holdings, Inc. (LDOS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 May 2022, 17:45.

Change

Previous filing in this sequence was filed on 16 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LDOS transaction

Common Stock

Award

Transaction value: $0
Shares: +1,106
Change %: +6.4%
Price: $0.000000
Shares after: 18,370
Date: 06 May 2022
Ownership: Direct

LDOS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,000
Date: 06 May 2022
Ownership: by Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LDOS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +1,784
Change %
Price: $0.000000
Shares after: 1,784
Date: 06 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,784
Exercise price: $104.06
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.